Table 2.
Mean costs of IVIg treatment in 29 patients with CIDP on long-term treatment: real costs using an outcome-measured treatment protocol vs. hypothetical costs using standard dosing at 1 g/kg every 3 weeks using (1) dosing weight and (2) recorded weight
| Mean Weekly IVIg Dose Used (g/week) |
Mean Yearly IVIg Dose Used (g/year) |
Mean Infusion Frequency (interval in weeks) |
Mean Infusion Duration (days) |
Mean Yearly IVIg Drug Costs GBP/patient (€) |
Mean Yearly IVIg infusion related non-drug costs GBP/patient (€) |
Mean Total Yearly IVIg related Costs GBP/patient (€) |
|
|---|---|---|---|---|---|---|---|
| Real IVIg consumption and costs incurred with Protocol and outcome measures used | 22.06 | 1149 | 4.34 | 2.79 | 37,660 (€ 43,309) |
17,115 (€ 19,682) |
54,775 (€ 62,991) |
| Consumption and costs with hypothetical standard dosing at 1 g/kg/ 3 weeks using dosing weight | 25.50 | 1326 | 3 | 2 | 43,532 (€ 50,062) |
17,749 (€ 20,411) |
61,281 (€ 70,473) |
| Consumption and costs with hypothetical standard dosing at 1 g/kg/ 3 weeks using recorded weight | 29.60 | 1539 | 3 | 2 | 50,532 (€ 58,119) |
17,749 (€ 20,411) |
68,281 (€ 78,523) |